A detailed history of Principal Financial Group Inc transactions in Ardelyx, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 135,439 shares of ARDX stock, worth $704,282. This represents 0.0% of its overall portfolio holdings.

Number of Shares
135,439
Previous 471,453 71.27%
Holding current value
$704,282
Previous $3.49 Million 73.29%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$5.28 - $7.57 $1.77 Million - $2.54 Million
-336,014 Reduced 71.27%
135,439 $933,000
Q2 2024

Jul 29, 2024

BUY
$5.89 - $9.31 $2.05 Million - $3.25 Million
348,642 Added 283.88%
471,453 $3.49 Million
Q1 2024

Apr 29, 2024

BUY
$6.05 - $9.74 $576,934 - $928,816
95,361 Added 347.4%
122,811 $896,000
Q4 2023

Feb 07, 2024

BUY
$3.29 - $6.64 $7,948 - $16,042
2,416 Added 9.65%
27,450 $170,000
Q3 2023

Nov 02, 2023

BUY
$3.3 - $4.83 $2,524 - $3,694
765 Added 3.15%
25,034 $102,000
Q2 2023

Aug 07, 2023

BUY
$3.23 - $4.95 $78,388 - $120,131
24,269 New
24,269 $82,000
Q2 2022

Aug 10, 2022

SELL
$0.51 - $1.17 $13,703 - $31,437
-26,870 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$0.65 - $1.18 $42 - $76
-65 Reduced 0.24%
26,870 $28,000
Q4 2021

Feb 09, 2022

SELL
$0.86 - $1.7 $4,902 - $9,691
-5,701 Reduced 17.47%
26,935 $30,000
Q3 2021

Nov 09, 2021

SELL
$1.27 - $8.17 $1,037 - $6,674
-817 Reduced 2.44%
32,636 $43,000
Q2 2021

Aug 10, 2021

SELL
$6.55 - $8.98 $445,386 - $610,622
-67,998 Reduced 67.03%
33,453 $253,000
Q1 2021

May 10, 2021

BUY
$6.1 - $7.69 $16,494 - $20,793
2,704 Added 2.74%
101,451 $672,000
Q4 2020

Feb 08, 2021

SELL
$5.05 - $7.1 $56,327 - $79,193
-11,154 Reduced 10.15%
98,747 $639,000
Q3 2020

Nov 06, 2020

BUY
$5.25 - $7.08 $191,178 - $257,818
36,415 Added 49.55%
109,901 $576,000
Q2 2020

Aug 05, 2020

BUY
$5.37 - $8.11 $394,619 - $595,971
73,486 New
73,486 $508,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $804M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.